284 related articles for article (PubMed ID: 15693892)
21. Heterogeneity of so-called neuroendocrine lung tumors.
Yesner R
Exp Mol Pathol; 2001 Jun; 70(3):179-82. PubMed ID: 11417996
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
23. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical neuroendocrine differentiation is an independent prognostic factor in surgically resected large cell carcinoma of the lung.
Harada M; Yokose T; Yoshida J; Nishiwaki Y; Nagai K
Lung Cancer; 2002 Nov; 38(2):177-84. PubMed ID: 12399130
[TBL] [Abstract][Full Text] [Related]
25. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma.
Hamilton K; Chiappori A; Olson S; Sawyers J; Johnson D; Washington K
Mod Pathol; 2000 May; 13(5):475-81. PubMed ID: 10824917
[TBL] [Abstract][Full Text] [Related]
27. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer.
Petrović M; Baskić D; Banković D; Ilić N
Biomarkers; 2011 Jun; 16(4):311-20. PubMed ID: 21595568
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
32. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung.
González-Aragoneses F; Moreno-Mata N; Cebollero-Presmanes M; García-Yuste M; Cañizares-Carretero MA; Molins-López-Rodó L; Quevedo-Losada S; Torres-Lanzas J; Alvarez-Fernández E;
Cancer; 2007 Oct; 110(8):1776-81. PubMed ID: 17724707
[TBL] [Abstract][Full Text] [Related]
34. Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation.
Fernandes AP; Capitanio A; Selenius M; Brodin O; Rundlöf AK; Björnstedt M
Histopathology; 2009 Sep; 55(3):313-20. PubMed ID: 19723146
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study.
Visscher DW; Zarbo RJ; Trojanowski JQ; Sakr W; Crissman JD
Mod Pathol; 1990 Jul; 3(4):508-12. PubMed ID: 2170973
[TBL] [Abstract][Full Text] [Related]
36. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study.
van Krimpen C; Elferink A; Broodman CA; Hop WC; Pronk A; Menke M
Breast; 2004 Aug; 13(4):329-33. PubMed ID: 15325669
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
38. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study.
Paci M; Cavazza A; Annessi V; Putrino I; Ferrari G; De Franco S; Sgarbi G
Ann Thorac Surg; 2004 Apr; 77(4):1163-7. PubMed ID: 15063227
[TBL] [Abstract][Full Text] [Related]
39. Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients.
Hastings RH; Laux AM; Casillas A; Xu R; Lukas Z; Ernstrom K; Deftos LJ
Clin Cancer Res; 2006 Jan; 12(2):499-506. PubMed ID: 16428492
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]